CA-ALTIUM
27.4.2022 08:32:11 CEST | Business Wire | Press release
Nexar, a business unit of Altium LLC, (ASX:ALU), has announced today the addition of the Industry Demand Index to the Spectra Electronic Design to Delivery Index (EDDI) report. Published monthly as a free subscription, EDDI gives in-depth analysis and actionable data intelligence into what is happening in the electronics component industry by comparing current insights with information sourced from more than two years of component history of tens of millions of parts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426006368/en/
Spectra is Nexar’s suite of electronic industry data intelligence offerings and products that helps businesses better anticipate supply chain challenges and opportunities. Spectra’s inaugural EDDI report, released in February 2022, offered the Industry Supply Index, which provides insights into the supply chain industry. With the addition of the Industry Demand Index to the latest EDDI, the data provides a clear look into component interest and how that will affect supply trends. These combined signals give a clear picture of the current supply and demand landscape that businesses can use to make smarter component selection decisions.
“The Altium ecosystem meets at the intersection of the design, supply chain and manufacturing domains. Our unique industry viewpoint positions our Nexar business unit to provide actionable insights on electronic component trends,” says Daniel Schoenfelder, Head of Nexar Sales and Octopart. “We are proud that EDDI is now the best free source of supply and demand business intelligence for stakeholders across the electronic component industry.”
A recent global survey conducted by IPC found that electronics manufacturers continue to be impacted by global shortages in semiconductors and other components and parts, which is contributing to production delays and uncertainty in the industry. As a result of the uncertainties, stakeholders need business intelligence to make better decisions across the design, supply chain, and manufacturing spectrum. Businesses can utilize EDDI in their engineering and business workflows to navigate issues they encounter with their bill of materials (BOM).
The EDDI is the only free industry report that provides comprehensive business intelligence on market conditions that can be leveraged by all stakeholders in the electronic component space. Spectra’s business intelligence offerings will continue to provide unparalleled transformational insights to the electronics industry.
The latest EDDI containing both supply and demand indices is now available on nexar.com/spectra/eddi , with new reports released each month. Subscribing to the EDDI guarantees to receive the most accurate supply chain insights sent directly to your inbox on a monthly basis.
To learn more about Spectra’s suite of data intelligence products or to get access to the latest EDDI, visit nexar.com/spectra .
About Nexar
Nexar is a Business Unit of Altium, LLC (ASX:ALU ). Altium, LLC, is a global software company headquartered in San Diego, California, who are accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426006368/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
